GeneralConnection.com ➔ Dictionary
Dictionary Search

organon

Synonyms

Noun

1. system

2. system of rules

Usage
Is Organon (OGN) Pricing Reflect Its Value After Reported Sun Pharma Takeover Interest - Yahoo Finance
Is Organon (OGN) Mispriced After A 58% One Year Share Price Slump? - simplywall.st
Organon pays $27.5M upfront for Sebela's hormone-free copper IUD - Fierce Biotech
New Analysis of Organon’s VTAMA® (tapinarof) cream, 1%, Phase 3 Data Showed Early and Consistent Improvement in Patient-Reported Sleep Subdomains in Pediatric Patients Down to 2 Years of Age with Atopic Dermatitis - BioSpace
Sun Pharma tight-lipped over rumoured $10B deal for Organon - FirstWord Pharma
Sun Pharma says talk of $10bn Organon bid is 'speculative' - pharmaphorum
Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel implant) 68 mg Radiopaque - Business Wire
Organon: Revenue Decline, Margin Pressure, And Strategic Uncertainty - Seeking Alpha
Direct Relief Announces 2025 Organon Community Health Awards Recipients - Direct Relief
Organon CEO stands down amid contraceptive sales malpractice probe - Pharmaceutical Technology
Sun Pharma Eyes Organon In What Could Be India Pharma's Biggest Cross-Border Deal: Report - Yahoo Finance
Does Organon’s 50% Share Price Slide Signal Opportunity in 2025? - Yahoo Finance
Is Organon (OGN) Now An Opportunity After Recent Share Price Weakness And DCF Upside? - Yahoo Finance
Organon (OGN) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
Organon & Co. (OGN) Posts FY Adjusted EPS of $3.66, EBITDA Margin at 30.7% - Yahoo Finance
Is It Time To Reassess Organon (OGN) After Its Sharp Multi Year Share Price Slide - Yahoo Finance
Assessing Organon (OGN) Valuation After Short Term Share Price Momentum And Long Term Weak Returns - Yahoo Finance
Assessing Organon (OGN) Valuation After A Sharp 30 Day Share Price Rebound - Yahoo Finance
Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock - Yahoo Finance
Organon (OGN) CIO logs stock awards and tax withholding share disposals - Stock Titan
Organon (OGN) CFO granted shares, withholds stock to pay taxes - Stock Titan
Can VTAMA’s Pediatric Sleep Data Nudge Organon (OGN) Toward a Stronger Dermatology-Led Growth Identity? - simplywall.st
Organon (NYSE:OGN) Posts Better-Than-Expected Sales In Q3 - Yahoo Finance
Organon (OGN) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
5 Revealing Analyst Questions From Organon’s Q4 Earnings Call - Yahoo Finance
Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device - Yahoo Finance
Organon CEO exits, company goes on hunt for successor as internal probe turns up 'improper' Nexplanon sales tactics - Fierce Pharma
Organon CEO Kevin Ali to resign after probe into contraceptive sales - Reuters
Scaling Sustainability: Organon’s Data Challenge - EcoVadis
Assessing Organon (OGN) Valuation After VTAMA Sleep Outcome Data From Phase 3 ADORING Trials - simplywall.st
Henlius and Organon score first US Perjeta biosimilar approval - Pharmaceutical Technology
Is Organon’s Recent 14% Price Jump Justified After Women’s Health Partnership News? - Yahoo Finance
Organon (NYSE: OGN) interim CEO reports stock awards and tax share offsets - Stock Titan
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Organon Details Nexplanon Sales Practice Issue - BioXconomy
Organon (OGN) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Q3 Rundown: Organon (NYSE:OGN) Vs Other Branded Pharmaceuticals Stocks - Yahoo Finance
TetraScience and Organon Collaborate to Modernize Quality Control Data Management - PR Newswire
Organon (OGN) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Organon Appoints Interim CEO and Board Chair; Reports Results of Audit Committee Investigation - New Jersey Business Magazine
UNFPA and Organon: Transforming women’s health through innovation and partnership - United Nations Population Fund
Organon divests Jada System, sends 100 employees to Laborie Medical Technologies in $465M deal - Fierce Biotech
Organon (OGN): Buy, Sell, or Hold Post Q3 Earnings? - Yahoo Finance
Organon CEO resigns after probe into 'improper' sales practices - FirstWord Pharma
Organon Completes Divestiture of JADA® System to Laborie - Yahoo Finance
Can Organon’s (OGN) Biosimilar Push Transform Its Competitive Position in US Oncology? - Yahoo Finance
Organon To Report Fourth Quarter and Full Year 2025 Results and Host Conference Call on February 12, 2026 - BioSpace
Organon Reports Results for the Third Quarter Ended September 30, 2025 - Business Wire
Is Organon’s 15% Share Price Jump a Sign of Real Value in 2025? - Yahoo Finance
Organon Announces Agreement to Divest its JADA® System for Up to $465 Million to Laborie - BioSpace
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales - Pharmaceutical Executive
How Investors Are Reacting To Organon (OGN) Lifting 2025 Guidance and CEO Share Purchase - Yahoo Finance
Organon (OGN) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Organon Secures FDA Approval Extending NEXPLANON Use to Five Years - Yahoo Finance
BRIEF—Sun Pharma clarifies $10 billion Organon acquisition report - The Pharma Letter
Why Organon (OGN) Shares Are Trading Lower Today - Yahoo Finance
Organon (OGN) Misses Q4 Earnings and Revenue Estimates - Yahoo Finance
Organon Completes Divesture of JADA System to Laborie Medical - Yahoo Finance
Executive Chairman of the Board of Organon Carrie Cox Buys 525% More Shares - Yahoo Finance
India’s Biggest Pharma Firm Said to Mull Bid for New York-Listed Organon - Bloomberg.com
Is Organon (OGN) Looking Mispriced After Recent Share Price Rebound? - simplywall.st
Why Organon (OGN) Is Up 13.4% After Expanding Nilemdo Rights In Six European Markets - Yahoo Finance
Organon (OGN) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance
Organon Reshapes Women’s Health Focus With Nexplanon Shift And Jada Sale - Yahoo Finance
Laborie acquires Jada from Organon in $465M deal - bioworld.com
Why Analysts See Organon’s Story Shifting Amid Governance Concerns And Lower Valuations - Yahoo Finance
Organon Completes Divesture of JADA System to Laborie Medical - Zacks Investment Research
Organon (OGN) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
Why Organon (OGN) Stock Is Down Today - Yahoo Finance
Organon (OGN) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Organon (OGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Assessing Organon Stock After a 39.5% Drop and Recent Portfolio Moves - Yahoo Finance
The Market Lifts Organon & Co. (NYSE:OGN) Shares 25% But It Can Do More - simplywall.st
Organon discontinues endometriosis drug after Phase II flunk - Clinical Trials Arena
Organon CEO resigns over 'improper' contraceptive sales - pharmaphorum
Organon (OGN) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance
Organon Earnings: What To Look For From OGN - Yahoo Finance
Great week for Organon & Co. (NYSE:OGN) institutional investors after losing 51% over the previous year - simplywall.st
Why Are Organon (OGN) Shares Soaring Today - Finviz
FDA expands use of Organon’s contraception implant up to 5 years - Medical Device Network
Laborie to acquire Organon’s JADA System for $465M - NJBIZ
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Organon Refocuses On Contraception With MIUDELLA Deal And JADA Exit - simplywall.st
Read This Before Considering Organon & Co. (NYSE:OGN) For Its Upcoming US$0.02 Dividend - Yahoo Finance
Organon poised to extend rally to seventh consecutive session - Seeking Alpha
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025 - BioSpace
Barclays Initiates Coverage of Organon (OGN) with Underweight Recommendation - Nasdaq
Did Leadership Shake-Up and Investigation Just Shift Organon's (OGN) Investment Narrative? - Yahoo Finance
Organon (OGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Organon (OGN) Is Down 12.8% After Earnings Miss And Flat 2026 Outlook Has The Bull Case Changed? - Yahoo Finance
Organon (OGN) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Organon & Co. (NYSE:OGN) Trading Down 6.3% - Time to Sell? - MarketBeat
Organon completes divestiture of Jada intrauterine vacuum device to Laborie - MassDevice
Organon (OGN) Outperforms Ahead of Earnings—Is Analyst Optimism Justified Amid Industry Changes? - Yahoo Finance
Earnings call transcript: Organon Q3 2025 beats forecasts, stock surges - Investing.com
UK watchdog slams AstraZeneca, Organon for marketing breaches - Fierce Pharma
Is There Now Opportunity in Organon Stock After Recent Double Digit Drop in 2025? - Yahoo Finance
Q2 Earnings Highs And Lows: Organon (NYSE:OGN) Vs The Rest Of The Branded Pharmaceuticals Stocks - Yahoo Finance
Why Organon (OGN) Stock Is Trading Up Today - Yahoo Finance
Organon completes sales of its JADA system to Laborie - ROI-NJ
Foreign Language Equivalents
Foreign Language Equivalents of 'organon'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
organo,   irganon,   oeganon,   orgabon,   organonn,   orgnaon,   organoon,   orhanon,   oranon,   ogranon,   oorganon,   oragnon,   orgaanon,   orgsnon,   orrganon,   orgaon,   organno,   orgamon,   orfanon,   organin,   orgnon,   erganon,   otganon,   roganon,   organn,   organnon,   rganon,   orgaonn,   organpn,   organob,   orgganon,   oganon,   organom,   prganon
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z